India to Thailand: Doxorubicin Export Trade Route
India has recorded 55 verified shipments of Doxorubicin exported to Thailand, representing a combined trade value of $1.8M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $32.4K USD. The leading Indian exporter is FRESENIUS KABI ONCOLOGY LIMITED, which accounts for 65% of total export value with 27 shipments worth $1.2M USD. On the buying side, FRESENIUS KABI (THAILAND) LTD is the largest importer in Thailand with $357.9K USD in purchases. The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , KHANDELWAL LABORATORIES PRIVATE LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Thailand Doxorubicin corridor is one of India's established pharmaceutical export routes, with 55 shipments documented worth a combined $1.8M USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 65% of all export value, reflecting the consolidated nature of India's doxorubicin manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $32.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with doxorubicin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 20.1%, placing it at rank #1 among India's top doxorubicin export destinations globally.
On the import side, key buyers of Indian doxorubicin in Thailand include FRESENIUS KABI (THAILAND) LTD, FRESENIUS KABI (THAILAND) LTD.,, FRESENIUS KABI THAILAND LTD and 18 others. FRESENIUS KABI (THAILAND) LTD is the single largest importer with 10 shipments valued at $357.9K USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ2
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#1
- Annual growth+20.1%
- Demand growth+19.0%
- Regulatory ease75/100
Top 10 Indian Doxorubicin Exporters to Thailand
Showing top 10 of 11 Indian suppliers exporting Doxorubicin to Thailand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI ONCOLOGY LIMITED Avg $42.7K per shipment | 27 | $1.2M | 64.7% |
| 2 | FRESENIUS KABI ONCOLOGY LIMITED Avg $43.3K per shipment | 11 | $476.4K | 26.7% |
| 3 | KHANDELWAL LABORATORIES PRIVATE LIMITED Avg $18.4K per shipment | 6 | $110.5K | 6.2% |
| 4 | KHANDELWAL LABORATORIES PRIVATE LIMITED Avg $18.2K per shipment | 2 | $36.4K | 2.0% |
| 5 | PROSPERA LIFE SCIENCES PRIVATE LIMITED Avg $910 per shipment | 2 | $1.8K | 0.1% |
| 6 | THERDOSE PHARMA PRIVATE LIMITED Avg $1.3K per shipment | 1 | $1.3K | 0.1% |
| 7 | MBA PHARMACEUTICALS PRIVATE LIMITED Avg $299 per shipment | 2 | $599 | 0.0% |
| 8 | GLS PHARMA LIMITED Avg $551 per shipment | 1 | $551 | 0.0% |
| 9 | VEA IMPEX (I) PRIVATE LIMITED Avg $347 per shipment | 1 | $347 | 0.0% |
| 10 | VEA IMPEX I PRIVATE LIMITED Avg $321 per shipment | 1 | $321 | 0.0% |
This table shows the top 10 of 11 Indian companies exporting doxorubicin to Thailand, ranked by total trade value. The listed exporters are: FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , KHANDELWAL LABORATORIES PRIVATE LIMITED, KHANDELWAL LABORATORIES PRIVATE LIMITED , PROSPERA LIFE SCIENCES PRIVATE LIMITED, THERDOSE PHARMA PRIVATE LIMITED , MBA PHARMACEUTICALS PRIVATE LIMITED, GLS PHARMA LIMITED, VEA IMPEX (I) PRIVATE LIMITED, VEA IMPEX I PRIVATE LIMITED. FRESENIUS KABI ONCOLOGY LIMITED is the dominant supplier with 27 shipments worth $1.2M USD, giving it a 65% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to Thailand Doxorubicin export route.
Top 10 Doxorubicin Importers in Thailand
Showing top 10 of 21 known buyers in Thailand receiving Doxorubicin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian doxorubicin in Thailand include FRESENIUS KABI (THAILAND) LTD, FRESENIUS KABI (THAILAND) LTD.,, FRESENIUS KABI THAILAND LTD, FRESENIUS KABI (THAILAND) LTD., , FRESENIUS KABI (THAILAND) LTD , among 21 total buyers. The largest importer is FRESENIUS KABI (THAILAND) LTD, accounting for $357.9K USD across 10 shipments — representing 20% of all doxorubicin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI (THAILAND) LTD | 10 | $357.9K | 20.1% |
| 2 | FRESENIUS KABI (THAILAND) LTD., | 6 | $269.4K | 15.1% |
| 3 | FRESENIUS KABI THAILAND LTD | 3 | $254.2K | 14.3% |
| 4 | FRESENIUS KABI (THAILAND) LTD., | 5 | $242.7K | 13.6% |
| 5 | FRESENIUS KABI (THAILAND) LTD | 6 | $233.7K | 13.1% |
| 6 | FRESENIUS KABI THAILAND LIMITED | 3 | $158.7K | 8.9% |
| 7 | FRESENIUS KABI(THAILAND)LTD | 3 | $94.6K | 5.3% |
| 8 | TMBTHANACHART BANK | 2 | $41.5K | 2.3% |
| 9 | TO THE ORDER OF | 2 | $36.4K | 2.0% |
| 10 | THE SIAM COMMERCIAL BANK | 2 | $36.0K | 2.0% |
Showing top 10 of 21 Doxorubicin importers in Thailand on this route.
Top 10 Doxorubicin Formulations Imported by Thailand
Showing top 10 of 38 product formulations shipped on the India to Thailand Doxorubicin route, ranked by trade value
Thailand imports a wide range of doxorubicin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ADRIM (DOXORUBICIN) INJ. USP 50MG/25ML V — accounts for $459.6K USD across 8 shipments. There are 38 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ADRIM (DOXORUBICIN) INJ. USP 50MG/25ML V | 8 | $459.6K | 25.8% |
| 2 | ADRIM DOXORUBICIN INJ. USP 50MG/25ML V | 2 | $149.0K | 8.4% |
| 3 | ADRIM DOXORUBICIN INJ USP 50MG 25ML VIAL BATCH NO 87230085AA 87230086AD 87230063AA MFG DT 02 2023 EXP DT 07 2024 | 1 | $142.9K | 8.0% |
| 4 | ADRIM (DOXORUBICIN) INJ. USP 50MG/25ML V | 2 | $127.6K | 7.2% |
| 5 | ADRIM(DOXORUBICIN)INJ.USP50MG/25MLVIALB NO-87240109AB/87240110AAMFG.03/24 EXP.08/2025 | 3 | $94.6K | 5.3% |
| 6 | ADRIM (DOXORUBICIN) INJ. USP 50MG/25ML VIAL BNO.87230519AA & 87230524AE, MFG. DT. 12/2023, EXP. DT. 05/2025NOS | 1 | $77.1K | 4.3% |
| 7 | ADRIM (DOXORUBICIN) INJ. USP 50MG/25ML VIAL, BATCH NO. 87240229AA, MFG. DT. 06/2024, EXP. DT. 11/2025, BATCH NO. 872402 | 1 | $69.5K | 3.9% |
| 8 | ADRIM (DOXORUBICIN) HCL INJ. USP 50MG/25ML VIAL BATCH NO. 87250097AA & 87250098AD MFG.03/2025,EXP.08/2026(12535 VIALS) | 1 | $69.4K | 3.9% |
| 9 | ADRIM (DOXORUBICIN HCL) INJ. USP 50MG/25ML VIAL BATCH NO. 87250035AA & 87250036AD,MFG.02/2025, EXP.07/2026(12193 VIALS) | 1 | $64.0K | 3.6% |
| 10 | ADRIM DOXORUBICIN INJ. USP 50MG/25ML VIAL BNO. 87230277AA, MANUFACTURING . DT. 06/2023,EXP. DT. 11/2024 | 1 | $61.6K | 3.5% |
Showing top 10 of 38 Doxorubicin formulations imported by Thailand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 18 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's doxorubicin exports to Thailand are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 27 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Thailand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , KHANDELWAL LABORATORIES PRIVATE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $32.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as adrim doxorubicin inj. usp 50mg/25ml v and adrim doxorubicin inj usp 50mg 25ml vial batch no 87230085aa 87230086ad 87230063aa mfg dt 02 2023 exp dt 07 2024, suggesting that buyers in Thailand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, FRESENIUS KABI (THAILAND) LTD is the largest importer with 10 shipments worth $357.9K USD — representing 20% of all doxorubicin imports from India on this route. A total of 21 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.8M
- Avg. Shipment
- $32.4K
- Suppliers
- 11
- Buyers
- 21
- Transit (Sea)
- ~31 days
- Annual Growth
- +20.1%
Related Analysis
Reverse Direction
Thailand → India — Doxorubicin (Import)Other Doxorubicin Routes
Unlock the Full India to Thailand Doxorubicin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 55 shipments on this route.
Frequently Asked Questions — India to Thailand Doxorubicin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Doxorubicin to Thailand?
The leading Indian exporters of Doxorubicin to Thailand are FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , KHANDELWAL LABORATORIES PRIVATE LIMITED. FRESENIUS KABI ONCOLOGY LIMITED holds the largest market share at approximately 65% of total trade value on this route.
Q What is the total value of Doxorubicin exports from India to Thailand?
India exports Doxorubicin to Thailand worth approximately $1.8M USD across 55 recorded shipments. The average value per shipment is $32.4K USD.
Q Which ports does India use to ship Doxorubicin to Thailand?
The most active port of origin is DELHI AIR with 18 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Thailand for Doxorubicin?
The average transit time for Doxorubicin shipments from India to Thailand is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Thailand Doxorubicin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 20.1% with demand growth tracking at 19.0%. The route is ranked #1 among India's top Doxorubicin export destinations globally.
Q How many suppliers are active on the India to Thailand Doxorubicin route?
There are currently 11 active Indian suppliers exporting Doxorubicin to Thailand. The market is moderately concentrated with FRESENIUS KABI ONCOLOGY LIMITED accounting for 65% of total shipment value.
Q Who are the main importers of Doxorubicin from India in Thailand?
The leading importers of Indian Doxorubicin in Thailand include FRESENIUS KABI (THAILAND) LTD, FRESENIUS KABI (THAILAND) LTD.,, FRESENIUS KABI THAILAND LTD, FRESENIUS KABI (THAILAND) LTD., , FRESENIUS KABI (THAILAND) LTD . FRESENIUS KABI (THAILAND) LTD is the largest buyer with 10 shipments worth $357.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Thailand export trade corridor identified from Indian Customs (DGFT) records for Doxorubicin.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 21 importers in Thailand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 55 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
55 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists